| Dr Amy Ann Mathew, MD | |
|
3534 Urbana Pike Ste A, Frederick, MD 21704-7786 | |
| (240) 341-1090 | |
| (240) 877-7110 |
| Full Name | Dr Amy Ann Mathew |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 3534 Urbana Pike Ste A, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205083102 | NPI | - | NPPES |
| 028290100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D0068729 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Ann Mathew, MD 3534 Urbana Pike Ste A, Frederick, MD 21704-7786 Ph: (240) 341-1090 | Dr Amy Ann Mathew, MD 3534 Urbana Pike Ste A, Frederick, MD 21704-7786 Ph: (240) 341-1090 |
News Archive
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
A lengthy study performed at Methodist Extended Care Hospital resulted in the elimination of potentially deadly infections. The study findings were reported in a scientific poster presentation at the recent annual meeting of the Association for Vascular Access (AVA), a leading national organization focusing on patient safety and best nursing practices.
For the last few years, women have heard conflicting reports about the risks and benefits of hormone replacement therapy (HRT). A new study that analyzes many trials together concludes that HRT can reduce heart attacks by about one-third in women under age 60 but has mixed results for older women.
Wealthy Americans are increasingly seeking help on how to navigate the Medicare system from financial advisers.
A new study, released today in the scientific journal Advances in Therapy is providing critical evidence that neurotechnology combined with saliva testing can drastically reduce the likelihood of falsely determining cannabis impairment due to THC residual detection.
› Verified 7 days ago
Joyce J Ghiorzi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1475 Taney Ave, Suite 201, Frederick, MD 21702 Phone: 301-662-1930 Fax: 240-379-6710 | |
Dr. Keith B St. Amand, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 87 Thomas Johnson Dr, Suite 101, Frederick, MD 21702 Phone: 301-694-0606 Fax: 301-662-6928 | |
Dr. Susan J Chaitovitz I, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1475 Taney Ave, Suite 201, Frederick, MD 21702 Phone: 301-662-0133 Fax: 240-379-6710 | |
Amy Marie Raynes, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 400 W Seventh St, Frederick, MD 21701 Phone: 240-566-3251 | |
Dr. Bharti Razdan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 400 W 7th St, Nicu, Frederick Memorial Hospital, Frederick, MD 21701 Phone: 240-566-3582 Fax: 240-566-3061 | |
Leena Shrivastava Dev, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 87 Thomas Johnson Dr Ste 101, Frederick, MD 21702 Phone: 301-694-0606 Fax: 301-662-6928 | |
Bophany Chea, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 87 Thomas Johnson Dr Ste 101, Frederick, MD 21702 Phone: 301-694-0606 Fax: 301-662-6928 |